Survival Benefit with Standard-Dose Decitabine Versus Standard-Dose Azacitidine in Patients with Lower-Risk Myelodysplastic Syndromes

Citations

WEB OF SCIENCE

0
제목
Survival Benefit with Standard-Dose Decitabine Versus Standard-Dose Azacitidine in Patients with Lower-Risk Myelodysplastic Syndromes
저자
Lee, Byung-Hyun; Kang, Ka-Won; Jeon, Min Ji; Yu, Eun Sang; Kim, Dae Sik; Choi, Hojoon; Lee, Se Ryun; Sung, Hwa Jung; Park, Yong; Choi, Chul Won; Kim, Byung Soo
DOI
10.1182/blood-2018-99-115694
발행일
2018-11-29
유형
Meeting Abstract
저널명
Blood
권
132